# Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

> **NCT00828672** · PHASE2 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 84 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Bevacizumab
- **DRUG:** Capecitabine
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT00828672
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-03
- **Final completion:** 2019-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828672, "Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00828672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*